Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Can loss of Lactobacillus reduce backup oxalate handling when Oxalobacter formigenes is absent?

Loss of Lactobacillus can reduce secondary microbial oxalate-handling capacity when Oxalobacter formigenes is absent.

PlausibleJuly 31, 202617 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Lactobacillus species include oxalate-degrading strains, so loss of Lactobacillus by PCR and culture can reduce backup microbial oxalate-handling capacity when Oxalobacter formigenes is absent.

laying out figure…
2 of 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says some Lactobacillus species can degrade oxalate and act as a backup when the primary oxalate-degrading specialist is missing. The mechanism framing highlights an Oxc-Frc pathway that supports oxalate catabolism and shows that losing these generalists can further lower overall oxalate clearance capacity.

Verified conclusion

The human gut microbiota plays a critical role in preventing hyperoxaluria and calcium oxalate kidney stones by metabolizing dietary oxalate. This metabolic function relies on a cooperative division of labor between specialized obligate degraders and generalist species.

Mechanistic pathways of oxalate degradation

  • Enzymatic machinery: Specific Lactobacillus species, including L. acidophilus, L. gasseri, and L. paracasei, harbor conserved frc (formyl-CoA transferase) and oxc (oxalyl-CoA decarboxylase) gene clusters.
  • Catabolic process: These adjacent, co-transcribed genes drive the Oxc-Frc pathway. Frc activates oxalate, and Oxc decarboxylates the intermediate, converting dietary oxalate into carbon dioxide and formate.
  • Strain-dependent capacity: Degradation efficiency is highly strain-specific. Under optimized in vitro conditions, select L. acidophilus strains achieve up to 100% oxalate degradation, while L. gasseri and L. paracasei strains routinely exhibit clearance rates ranging from 45% to over 68%.

Impact of dual depletion

  • Loss of primary specialist: Oxalobacter formigenes is the host's primary, highly efficient oxalate-degrading specialist. Its absence compromises the primary intestinal pathway for oxalate clearance.
  • Compromised backup capacity: When O. formigenes is missing, generalist Lactobacillus species serve as a crucial secondary metabolic buffer.
  • Clinical implications: Ecological modeling shows that a concurrent loss of Lactobacillus—identifiable through PCR and culture—depletes this secondary backup pool. Without this backup, the host lacks the adaptive capacity to handle dietary oxalate loads, increasing the risk of hyperoxaluria.

Bottom line

  • Specific Lactobacillus strains possess functional Oxc-Frc metabolic pathways that actively degrade oxalate. When the primary specialist Oxalobacter formigenes is absent, the loss of these Lactobacillus generalists removes the host's secondary microbial buffer, directly reducing overall oxalate-handling capacity.

References

  1. Transcriptional and Functional Analysis of Oxalyl-Coenzyme A ... — pmc.ncbi.nlm.nih.gov ↗
  2. Oxalate-Degrading Activity in Bifidobacterium animalis ... — journals.asm.org ↗
  3. Discussion — academic.oup.com ↗
  4. Assessment of in vitro oxalate degradation by Lactobacillus ... — pubmed.ncbi.nlm.nih.gov ↗
  5. Metabolomic profiling of oxalate-degrading probiotic ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  6. Screening of different probiotic strains for their in vitro ... — pubmed.ncbi.nlm.nih.gov ↗
  7. Evaluation of Oxalobacter formigenes DSM 4420 biodegradation activity for high oxalate media content: An in vitro model. — pmc.ncbi.nlm.nih.gov ↗
  8. Gut microbiota and oxalate homeostasis. — pmc.ncbi.nlm.nih.gov ↗
  9. Probiotic Oxalate-Degrading Bacteria - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  10. Complex system modeling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria — pmc.ncbi.nlm.nih.gov ↗
  11. Therapeutic effects of probiotics and herbal medications on oxalate ... — pmc.ncbi.nlm.nih.gov ↗
  12. how gut microbiome correlates with oxalate, butyrate and kidney — open.library.ubc.ca ↗
  13. Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease — elifesciences.org ↗
  14. Baseline abundance of oxalate-degrading bacteria ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  15. Baseline abundance of oxalate-degrading bacteria determines response to Oxalobacter formigenes probiotic therapy — tandfonline.com ↗
  16. Detection of oxalyl-CoA decarboxylase (oxc) and formyl-CoA transferase (frc) genes in novel probiotic isolates capable of oxalate degradation in vitro - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  17. Bioinformatic Analysis of Oxalate-Degrading Enzymes in ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→